Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» October 2010
October 2010
Big Pharma Embraces Branded Generics
Big Pharma Embraces Branded Generics
Seeking Alpha
Big Pharma
Abbott Laboratories
GSK
Pfizer
Novartis
AstraZeneca
Eli Lilly
Sun Pharma unimpressed with Taro results
Sun Pharma unimpressed with Taro results
Globes, Israel
Sun Pharma
Taro
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Seeking Alpha
Teva Pharmaceuticals
Sanofi
Pfizer
Pacific Biosciences
Merck
Macrogenics
Hikma
GSK
BMP Sunstone
biotech
Baxter International
Amicus Therapeutics
Immune Design
MedImmune
GSK's Whistle-Blowing Record Is a Good Thing
GSK's Whistle-Blowing Record Is a Good Thing
Seeking Alpha
GSK
legal
AstraZeneca Q3 profit down 27 pct amid legal costs
AstraZeneca Q3 profit down 27 pct amid legal costs
TMCnet
AstraZeneca
earnings
Sanofi-Aventis lifts outlook as Q3 profit rises
Sanofi-Aventis lifts outlook as Q3 profit rises
TMCnet
Sanofi
earnings
New Data Analyses on CONCERTA Pediatric Treatment Include Insight on Handwriting Performance and Attention in ADHD
New Data Analyses on CONCERTA Pediatric Treatment Include Insight on Handwriting Performance and Attention in ADHD
Pipeline Review
Concerta
Ortho-McNeil-Janssen
ADHD
Forest and Almirall Report Preliminary Topline Results from the ACCORD COPD II Phase III Study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD)
Forest and Almirall Report Preliminary Topline Results from the ACCORD COPD II Phase III Study of aclidinium bromide in Chronic Obstructive Pulmonary Disease (COPD)
Pipeline Review
Forrest
Almirall
COPD
aclidinium bromide
Sun Pharma consolidated Q2 net up at Rs 504-cr
Sun Pharma consolidated Q2 net up at Rs 504-cr
istockanalyst
Sun Pharma
Savient: Risky but Promising Small Cap
Savient: Risky but Promising Small Cap
Seeking Alpha
Savient
gout
Oxandrin
Krystexxa
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »